A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
about
Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate CancerAdverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic ReviewMoving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.
P2860
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
@ast
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
@en
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer
@nl
type
label
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
@ast
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
@en
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer
@nl
prefLabel
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
@ast
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
@en
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer
@nl
P2860
P356
P1433
P1476
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).
@en
P2093
John M Lacy
Natasha Kyprianou
P2860
P304
P356
10.3892/OL.2014.2388
P577
2014-07-28T00:00:00Z